Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernhard Kratzer

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Human Genetics|November 29, 2022
A homozygous AP3D1 missense variant in patients with sensorineural hearing loss as the leading manifestationAlexandra Frohne, Martin Koenighofer, Hakan Cetin, et al.
Nature Immunology|June 24, 2020
Serum amyloid A is a soluble pattern recognition receptor that drives type 2 immunityUrsula Smole, Naina Gour, Jordan Phelan, et al.
Vaccines|April 27, 2024
Flow Cytometry-Based Measurement of Antibodies Specific for Cell Surface-Expressed Folded SARS-CoV-2 Receptor-Binding DomainsAl Nasar Ahmed Sehgal, Jera Safran, Bernhard Kratzer, et al.
Frontiers in Immunology|October 7, 2024
Cytosolic nucleic acid sensors and interferon beta-1 activation drive radiation-induced anti-tumour immune effects in human pancreatic cancer cellsSylvia Kerschbaum-Gruber, Ava Kleinwächter, Katerina Popova, et al.
Ebiomedicine|September 6, 2023
Lower magnitude and faster waning of antibody responses to SARS-CoV-2 vaccination in anti-TNF-α-treated IBD patients are linked to lack of activation and expansion of cTfh1 cells and impaired B memory cell formationErika Garner-Spitzer, Angelika Wagner, Venugopal Gudipati, et al.
The Journal of Allergy and Clinical Immunology|June 23, 2022
Art v 1 IgE epitopes of patients and humanized mice are conformationalMaja Zabel, Milena Weber, Bernhard Kratzer, et al.
Frontiers in Immunology|May 31, 2022
SARS-CoV-2-mRNA Booster Vaccination Reverses Non-Responsiveness and Early Antibody Waning in Immunocompromised Patients - A Phase Four Study Comparing Immune Responses in Patients With Solid Cancers, Multiple Myeloma and Inflammatory Bowel DiseaseAngelika Wagner, Erika Garner-Spitzer, Anna-Margarita Schötta, et al.
Allergy|July 14, 2024
Differential decline of SARS-CoV-2-specific antibody levels, innate and adaptive immune cells, and shift of Th1/inflammatory to Th2 serum cytokine levels long after first COVID-19Bernhard Kratzer, Pia Gattinger, Doris Trapin, et al.
Frontiers in Immunology|October 17, 2025
Severe COVID-19 induces prolonged elevation of the acute-phase protein pentraxin 3Bernhard Kratzer, Robert B Stieger, Seyma Durmus, et al.
Allergy|October 31, 2020
Immunological imprint of COVID-19 on human peripheral blood leukocyte populationsBernhard Kratzer, Doris Trapin, Paul Ettel, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Human Genetics|November 29, 2022
A homozygous AP3D1 missense variant in patients with sensorineural hearing loss as the leading manifestationAlexandra Frohne, Martin Koenighofer, Hakan Cetin, et al.
Nature Immunology|June 24, 2020
Serum amyloid A is a soluble pattern recognition receptor that drives type 2 immunityUrsula Smole, Naina Gour, Jordan Phelan, et al.
Vaccines|April 27, 2024
Flow Cytometry-Based Measurement of Antibodies Specific for Cell Surface-Expressed Folded SARS-CoV-2 Receptor-Binding DomainsAl Nasar Ahmed Sehgal, Jera Safran, Bernhard Kratzer, et al.
Frontiers in Immunology|October 7, 2024
Cytosolic nucleic acid sensors and interferon beta-1 activation drive radiation-induced anti-tumour immune effects in human pancreatic cancer cellsSylvia Kerschbaum-Gruber, Ava Kleinwächter, Katerina Popova, et al.
Ebiomedicine|September 6, 2023
Lower magnitude and faster waning of antibody responses to SARS-CoV-2 vaccination in anti-TNF-α-treated IBD patients are linked to lack of activation and expansion of cTfh1 cells and impaired B memory cell formationErika Garner-Spitzer, Angelika Wagner, Venugopal Gudipati, et al.
The Journal of Allergy and Clinical Immunology|June 23, 2022
Art v 1 IgE epitopes of patients and humanized mice are conformationalMaja Zabel, Milena Weber, Bernhard Kratzer, et al.
Frontiers in Immunology|May 31, 2022
SARS-CoV-2-mRNA Booster Vaccination Reverses Non-Responsiveness and Early Antibody Waning in Immunocompromised Patients - A Phase Four Study Comparing Immune Responses in Patients With Solid Cancers, Multiple Myeloma and Inflammatory Bowel DiseaseAngelika Wagner, Erika Garner-Spitzer, Anna-Margarita Schötta, et al.
Allergy|July 14, 2024
Differential decline of SARS-CoV-2-specific antibody levels, innate and adaptive immune cells, and shift of Th1/inflammatory to Th2 serum cytokine levels long after first COVID-19Bernhard Kratzer, Pia Gattinger, Doris Trapin, et al.
Frontiers in Immunology|October 17, 2025
Severe COVID-19 induces prolonged elevation of the acute-phase protein pentraxin 3Bernhard Kratzer, Robert B Stieger, Seyma Durmus, et al.
Allergy|October 31, 2020
Immunological imprint of COVID-19 on human peripheral blood leukocyte populationsBernhard Kratzer, Doris Trapin, Paul Ettel, et al.
Pageof 4